Anti-CD9 antibody [EPR27551-92]
- BOND RX™ Validated
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(42 Publications)
Anti-CD9 antibody [EPR27551-92] (ab307085) is a rabbit monoclonal antibody detecting CD9 in Western Blot, IP, IHC-P. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
View Alternative Names
CD9, MIC3, TSPAN29, GIG2, CD9 antigen, 5H9 antigen, Cell growth-inhibiting gene 2 protein, Leukocyte antigen MIC3, Motility-related protein, Tetraspanin-29, p24, MRP-1, Tspan-29
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD9 antibody [EPR27551-92] (AB307085)
Immunohistochemical analysis of paraffin-embedded Rat kidney tissue labeling CD9 with ab307085 at 1/2000 (0.228 µg/ml) followed by a LeicaDS9800 (Bond™ Polymer Refine Detection) was used at Ready to use dilution. Membranous staining in rat kidney. The section was incubated with ab307085 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is LeicaDS9800 (Bond™ Polymer Refine Detection) was used at Ready to use dilution. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD9 antibody [EPR27551-92] (AB307085)
Immunohistochemical analysis of paraffin-embedded Mouse kidney tissue labeling CD9 with ab307085 at 1/2000 (0.228 µg/ml) followed by a LeicaDS9800 (Bond™ Polymer Refine Detection) was used at Ready to use dilution. Positive staining in mouse kidney. The section was incubated with ab307085 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is LeicaDS9800 (Bond™ Polymer Refine Detection) was used at Ready to use dilution. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD9 antibody [EPR27551-92] (AB307085)
Immunohistochemical analysis of paraffin-embedded Mouse cerebrum tissue labeling CD9 with ab307085 at 1/2000 (0.228 µg/ml) followed by a LeicaDS9800 (Bond™ Polymer Refine Detection) was used at Ready to use dilution. Positive staining in mouse cerebrum. The section was incubated with ab307085 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is LeicaDS9800 (Bond™ Polymer Refine Detection) was used at Ready to use dilution. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD9 antibody [EPR27551-92] (AB307085)
Immunohistochemical analysis of paraffin-embedded Mouse lung cancer tissue labeling CD9 with ab307085 at 1/2000 (0.228 µg/ml) followed by a LeicaDS9800 (Bond™ Polymer Refine Detection) was used at Ready to use dilution. Membranous staining in mouse lung cancer. The section was incubated with ab307085 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is LeicaDS9800 (Bond™ Polymer Refine Detection) was used at Ready to use dilution. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CD9 antibody [EPR27551-92] (AB307085)
Immunohistochemical analysis of paraffin-embedded Rat cerebrum tissue labeling CD9 with ab307085 at 1/2000 (0.228 µg/ml) followed by a LeicaDS9800 (Bond™ Polymer Refine Detection) was used at Ready to use dilution. Positive staining in rat cerebrum. The section was incubated with ab307085 for 30 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin. Secondary antibody only control : Secondary antibody is LeicaDS9800 (Bond™ Polymer Refine Detection) was used at Ready to use dilution. Heat mediated antigen retrieval with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 mins
- IP
Supplier Data
Immunoprecipitation - Anti-CD9 antibody [EPR27551-92] (AB307085)
CD9 was immunoprecipitated from 0.35 mg RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate 10 μg with ab307085 at 1/30 dilution (2μg in 0.35mg lysates). Western blot was performed on the immunoprecipitate using ab307085 at 1/1000 dilution. VeriBlot for IP secondary antibody(HRP)(ab131366) was used at 1/5000 dilution. Lane 1 : RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate 10 μg Lane 2 : ab307085 IP in RAW 264.7 whole cell lysate Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab307085 in RAW 264.7 whole cell lysate Blocking and dilution buffer and concentration : 5% NFDM/TBST. Exposure time : 10 seconds
All lanes:
Immunoprecipitation - Anti-CD9 antibody [EPR27551-92] (ab307085) at 1/30 dilution
All lanes:
RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage)
Secondary
All lanes:
Immunoprecipitation - VeriBlot for IP Detection Reagent (HRP) (<a href='/en-us/products/reagents/veriblot-for-ip-detection-reagent-hrp-ab131366'>ab131366</a>) at 1/5000 dilution
Observed band size: 23 kDa
false
Exposure time: 10s
- WB
Supplier Data
Western blot - Anti-CD9 antibody [EPR27551-92] (AB307085)
Blocking and diluting buffer and concentration : Intercept® (TBS) Blocking Buffer diluted with an equal volume of 0.1% TBS The samples were run on a Bis-Tris gel. Performed under reducing conditions. False colour image of Western blot : Anti-CD9 antibody [EPR27551-92] (ab307085) staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab307085 was shown to bind specifically to CD9. A band was observed at 23 kDa in wild-type HeLa cell lysates whereas no signal observed at this size in CD9 knockout cell line ab255375 (knockout cell lysate ab263754). To generate this image, wild-type and CD9 knockout HeLa cell lysates were analyzed. First, samples were run on an SDS-PAGE gel then transferred onto an immobilon-FL PVDF membrane. Membranes were blocked in in Intercept® (TBS) Blocking Buffer diluted with an equal volume of 0.1% TBS before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-CD9 antibody [EPR27551-92] (ab307085) at 1/1000 dilution
Lane 1:
Wild-type HeLa (human cervical adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
CD9 knockout HeLa whole cell lysate at 20 µg
Lane 3:
MCF7 (human breast adenocarcinoma epithelial cell) whole cell lysate at 20 µg
Lane 4:
RAW 264.7 (mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg
Secondary
Lanes 1 - 4:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Lanes 1 - 4:
Western blot - Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (<a href='/en-us/products/secondary-antibodies/goat-mouse-igg-h-l-irdye-680rd-preadsorbed-ab216776'>ab216776</a>) at 1/10000 dilution
Observed band size: 23 kDa
false
- WB
Supplier Data
Western blot - Anti-CD9 antibody [EPR27551-92] (AB307085)
Blocking and diluting buffer and concentration : 5% NFDM/TBST Negative controls : K-562, Raji (PMID : 17407154 ; PMID : 8921952). Exposure time : 70 seconds
All lanes:
Western blot - Anti-CD9 antibody [EPR27551-92] (ab307085) at 1/1000 dilution
Lane 1:
HCT 116 (human colorectal carcinoma epithelial cell) whole cell lysate at 20 µg
Lane 2:
K-562 (human chronic myelogenous leukemia lymphoblast) whole cell lysate at 20 µg
Lane 3:
Raji (human Burkitts lymphoma B lymphocyte) whole cell lysate at 20 µg
Lane 4:
Mouse brain tissue lysate at 20 µg
Lane 5:
Mouse kidney tissue lysate at 20 µg
Lane 6:
C6 (rat glial tumor glial cell) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Observed band size: 23 kDa
false
Exposure time: 70s
Related conjugates and formulations (1)
-
Anti-CD9 antibody [EPR27551-92] - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
Anti-CD9 antibody [EPR27551-92] (ab307085) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunoprecipitation (IP), Immunohistochemistry (IHC-P) in Human, Mouse, Rat samples.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-CD9 antibody [EPR27551-92] (ab307085) has been confirmed by Western blot testing in CD9 Knockout HeLa cell line, ab255375.
Other related products
We have a range of other formats of antibody clone [EPR27551-92] also available for your convenience: ab307085, Carrier free - ab307086
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The CD9 protein is integral to cell adhesion migration and fusion. It forms complexes with other tetraspanins and proteins like EWI-2 and EWI-F contributing to cellular signaling and membrane compartmentalization. Additionally CD9 plays an important role in the formation and secretion of exosomes tiny vesicles emitted by cells that mediate cell-to-cell communication. These exosomes can be analyzed using tools like exosome assays and detection kits that target CD9 proteins.
Pathways
CD9 is involved in the regulation of immune response and cell morphology. It participates in pathways such as the integrin signaling pathway and the phosphatidylinositol 3-kinase (PI3K) signaling pathway. CD9 modulates these interactions by associating with proteins such as integrins and other members of the tetraspanin family influencing cellular movement and proliferation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (42)
Recent publications for all applications. Explore the full list and refine your search
BMC cancer 25:1553 PubMed41073958
2025
Applications
Unspecified application
Species
Unspecified reactive species
Stem cell research & therapy 16:414 PubMed40739581
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bioactive materials 53:58-71 PubMed40688017
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of orthopaedic translation 53:187-205 PubMed40678612
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in immunology 16:1548802 PubMed40534860
2025
Applications
Unspecified application
Species
Unspecified reactive species
International journal of nanomedicine 20:6929-6948 PubMed40458745
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of orthopaedic surgery and research 20:539 PubMed40442730
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biology direct 20:61 PubMed40399992
2025
Applications
Unspecified application
Species
Unspecified reactive species
Materials today. Bio 32:101810 PubMed40391025
2025
Applications
Unspecified application
Species
Unspecified reactive species
Chemical biology & drug design 105:e70118 PubMed40317686
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com